Style de citation APA (7e éd.)

LD, M., P, T., & AC, L. (2019). CPX-351: A nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties. Dove Medical Press.

Style de citation Chicago (17e éd.)

LD, Mayer, Tardi P, et Louie AC. CPX-351: A Nanoscale Liposomal Co-formulation of Daunorubicin and Cytarabine with Unique Biodistribution and Tumor Cell Uptake Properties. Dove Medical Press, 2019.

Style de citation MLA (8e éd.)

LD, Mayer, et al. CPX-351: A Nanoscale Liposomal Co-formulation of Daunorubicin and Cytarabine with Unique Biodistribution and Tumor Cell Uptake Properties. Dove Medical Press, 2019.